Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
03/2008
03/25/2008US7348315 Methods of treating heart failure with modified ATP, ADP and AMP compounds
03/25/2008US7348146 Single nucleotide polymorphism analysis of highly polymorphic target sequences
03/25/2008CA2426754C Indolocarbazole anticancer agents and methods of using them
03/25/2008CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression
03/20/2008WO2008032103A2 Process for the preparation of an (rp)-8-substituted camps
03/20/2008WO2008016909A3 Nucleotide analogs
03/20/2008WO2006000883A3 Chemical synthesis of s-adenosyl-l-methionine with enrichment of (s,s)-isomer
03/20/2008US20080071070 Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides
03/20/2008US20080070861 Therapy for infections such as hepatitis virus using a (2'R)-2'-deoxy-2'-fluoro-2'-C-methyl nucleosides; rhinovirus; Dengue virus (DENV) or West Nile virus
03/20/2008US20080070860 Purine nucleoside analogs that are selective ligands of the purine salvage pathway enzyme adenosine phosphorylase (AP) found in bacteria and protozoa; 2-chloro-5'-deoxyadenosine; 2-chloro-6-methylpurine-5'-deoxyriboside
03/20/2008US20080070859 Treats neoplastic disorders, infections from fungal or fungal-like organisms and other parasites
03/20/2008US20080070852 Immunomodulators; therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus; 5-Amino-3-(5'-O-L-valinyl- beta -D-ribofuranosyl)thiazolo[4,5-d]pyrimidine-2,7-dione Dihydrochloride
03/20/2008DE102006037786A1 Nukleoside, diese enthaltendes Arzneimittel und deren Verwendung Nucleosides containing these drugs and their use
03/20/2008CA2662565A1 Process for the preparation of an (rp)-8-substituted camps
03/19/2008EP1899361A1 Reagent for the improved synthesis of isoguanosine-containing oligonucleotides
03/19/2008EP1898934A1 Nucleosides with non-natural bases as anti-viral agents
03/19/2008EP1575974B1 Modified guanosines having flavouring activity
03/19/2008CN101146519A Solid oral dosage form of valopi citabine (VAL-MCYD) and method of preparing it
03/18/2008US7345164 Production method of 5′-acyloxynucleoside compound
03/18/2008US7345159 Massive parallel method for decoding DNA and RNA
03/18/2008CA2388050C Antibiotic caprazamycins and process for producing the same
03/18/2008CA2278313C Fluorescent cyanine dyes
03/18/2008CA2219659C Rapamycin derivatives
03/13/2008WO2008014252A3 Iap inhibitors
03/13/2008US20080064868 Novel Dideoxynucleoside Derivatives
03/13/2008US20080064655 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B
03/12/2008EP1897882A1 N2-quinolyl or isoquinolyl substituted purine derivatives, the preparation and uses thereof
03/12/2008EP1896850A2 Aptamers that bind to prion protein
03/12/2008EP1896489A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
03/12/2008EP1895841A2 Methods for selective n-9 glycosylation of purines
03/12/2008EP1546168A4 Photoactivated anti-viral and anti-cancer agent
03/12/2008CN101142226A Tricyclic-nucleoside prodrugs for treating viral infections
03/12/2008CN100374454C preparation method of 2-aminocarbonyl-9h-purine derivatives and intermediate thereof
03/11/2008US7342108 De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
03/11/2008US7342003 Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
03/11/2008CA2288147C Anti-viral pyrimidine nucleoside analogues
03/06/2008WO2008026729A1 Therapeutic agent for pigmented villonodular synovitis or giant cell tumor of tendon sheath or bone
03/06/2008WO2008025886A1 Metal chelates and chelating agents containing triazolyl subunits
03/06/2008WO2008025160A1 Oxepane nucleosides and oligonucleotides, uses thereof and methods of making the same
03/06/2008WO2007112028A3 2'-fluoronucleoside phosphonates as antiviral agents
03/06/2008US20080058509 Method for the Preparation of D-Erythro-2,2-Difluoro-2-Deoxy-1-Oxoribose Derivative
03/06/2008US20080056988 [18f]-furanosylpurine derivatives and uses thereof
03/05/2008EP1575971A4 Process for the production of 3 -nucleoside prodrugs
03/05/2008EP0638089B2 Synthesis of diverse and useful collections of oligonucleotides
03/05/2008CN100372863C Nucleotide derivatives and DNA microarray
03/04/2008US7339054 Reacting 2-Anhydro-3,5-di-O-(p-toluoyl)-2-C-methyl- alpha -D-ribofuranose with nucleophile such as cytosine, uracil, thymine, hypoxanthine, adenine, guanine, 7-deazaguanine, 7-deazaadenine, 7-deaza-2,6-diaminopurine, and 7-deazahypoxanthine
03/04/2008US7339053 4′-C-substituted-2-haloadenosine derivative
03/04/2008US7339045 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, lipids, cells, virus particles, fatty acids, polysaccharides)
03/04/2008US7338932 Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
03/04/2008US7338762 Attached covalently to one or more beads; dispersing the probe beads in a thixotropic agent, scanning for a detectable signal, isolating the target biomolecule; high throughput assays
03/04/2008US7338666 Methods for modulating the axonal outgrowth of central nervous system neurons
03/04/2008CA2426613C Hydrogelatinizer
02/2008
02/28/2008WO2008022469A1 2'-DEOXY-2'-FLUORO-β-D-ARABINONUCLEOSIDE 5'-TRIPHOSPHATES AND THEIR USE IN ENZYMATIC NUCLEIC ACID SYNTHESIS
02/28/2008US20080051571 Silyl Linker For Solid-Phase Synthesis Of Nucleic Acid
02/28/2008US20080051353 Avermectin And Avermectin Monosaccharide Substituted In The 4"- And 4" Position Respectively
02/28/2008US20080051315 Grp Receptor-Related Methods for the Treating and Preventing Fear-Related Disorders
02/28/2008US20080051299 DNA-protein fusions and uses thereof
02/28/2008US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture
02/28/2008US20080050780 reduces number of steps required for identification of each base of a polynucleotide; nucleoside in which a phosphate moiety label is attached to base and a phosphate moiety protecting group is attached to sugar, and are detachable from said nucleoside by a phosphatase enzyme; blocking group
02/27/2008EP1891951A1 Viral polymerase inhibitors
02/27/2008EP1891950A1 Viral polymerase inhibitors
02/27/2008EP1891087A1 Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
02/27/2008EP1890537A1 Methods of treating cancer and other conditions or disease states using lfmau and ldt
02/27/2008CN101133072A Hydrogels for the controlled release of bioactive materials
02/26/2008US7335765 Nucleoside and oligonucleotide analogues
02/26/2008US7335648 Thrombosis; anticoagulants; renal dialysis
02/26/2008US7335500 Generating preferential fucose compound; obtain sample, incubate with fucosyltransferae, recover fucosylated compound
02/21/2008WO2008020560A1 Antibacterial agent and therapeutic agent for johne's disease comprising the same
02/21/2008WO2008000743A3 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists
02/21/2008US20080045473 Compositions and methods for oligonucleotide formulations
02/21/2008US20080045457 Ancestral Hepatitis C virus envelope protein sequence
02/20/2008EP1889846A1 Purine derivatives as A2a agonists
02/20/2008EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
02/20/2008CN101128474A Tricyclic-nucleoside prodrugs for treating viral infections
02/20/2008CN101128473A Adenosine derivatives having a2a receptor activity
02/20/2008CN101128472A Process for fluorocytidine derivatives
02/20/2008CN101125872A Nucleoside analog and diastereoselectivity preparation method for derivative of the same
02/20/2008CN100369926C Nucleotide lipid ester derivatives
02/19/2008US7332479 Extracellular NAD+ and cADPR as potent anti-inflammatory agents
02/19/2008US7332477 Visible light and ultraviolet (UV) light sensitive composition for DNA transfer comprising an acid sensitive gene transfer agent, a photoacid generator, and a bioactive agent
02/14/2008WO2007149891A3 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof
02/14/2008US20080039412 Short interfering RNA sequences for use in therapeutic, veterinary, agricultural, diagnostic, target validation, and genomic discovery applications
02/14/2008US20080038745 Nucleotide analogs with six-membered rings
02/14/2008US20080038242 sodium-dependent nucleoside transporter 2 inhibitors; for diseases associated with abnormal plasma uric acid levels such as gout, hyperuricemia, urinary lithiasis, hyperuriciemic nephropathy, and acute uric acid nephropathy
02/13/2008EP1887013A1 A process for preparing didanosine
02/13/2008EP1885876A2 Macromolecular nucleotide links and methods for their use
02/13/2008EP1470148A4 Double-stranded oligonucleotides
02/13/2008EP1373286A4 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support
02/13/2008EP1233770B1 Phosphonate compounds
02/13/2008CN101120947A Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b
02/13/2008CN100368422C L-nucleic acid derivatives and processes for synthesis thereof
02/12/2008US7329496 Sequencing of surface immobilized polymers utilizing microflourescence detection
02/12/2008CA2194658C Novel dipteran-active compound and bacillus thuringiensis strain
02/07/2008WO2008016909A2 Nucleotide analogs
02/07/2008WO2008016907A1 Nucleotide analogs
02/07/2008WO2008016244A1 Naphthalene 2-carboxylate derivative useful for synthesizing gemcitabine and a method for preparing the same
02/07/2008WO2008016079A1 Method for introducing nucleic-acid-protecting group
02/07/2008WO2007111954A3 Purine compounds and methods of use thereof
02/07/2008US20080032945 2'-modified oligonucleotides
02/07/2008US20080032379 Pyrenyloxysulfonic acid flurescent agents
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 201